Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-12-002912
Filing Date
2012-08-13
Accepted
2012-08-13 09:49:27
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q alrx_10q.htm 10-Q 661050
2 CERTIFICATION alrx_ex311.htm EX-31.1 19261
3 CERTIFICATION alrx_ex321.htm EX-32.1 5984
  Complete submission text file 0001477932-12-002912.txt   2661574

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT alrx-20120630.xml EX-101.INS 231470
5 XBRL TAXONOMY EXTENSION SCHEMA alrx-20120630.xsd EX-101.SCH 37096
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrx-20120630_cal.xml EX-101.CAL 35040
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrx-20120630_def.xml EX-101.DEF 71756
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrx-20120630_lab.xml EX-101.LAB 196347
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrx-20120630_pre.xml EX-101.PRE 133690
Mailing Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3
Business Address 168 KONRAD CRESCENT SUITE 200 MARKHAM A6 V6E2K3 (905) 479-3245
ALPHARX INC (Filer) CIK: 0001114936 (see all company filings)

EIN.: 980177440 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-30813 | Film No.: 121026226
SIC: 2834 Pharmaceutical Preparations